PRODUCT DETAILS VIEW ALL PRODUCTS

Zolipid Tablet (Zolpidem )

  • Each Tablet contains 10 mg of zolpidem tartrate.
  • Treatment of insomnia.
  • Subunit modulation of the GABAA receptor chloride channel macromolecular complex is hypothesized to be responsible for sedative, anticonvulsant, anxiolytic, and myorelaxant drug properties.
  • 10 mg once daily immediately before bedtime
  • Known hypersensitivity to zolpidem tartrate or to any of the inactive ingredients in the formulation.
  • Severe anaphylactic/ anaphylactoid reactions, abnormal thinking, behavioral changes and complex behaviors. Symptoms may occur with rapid dose reduction or discontinuation, worsening of depression or, suicidal thinking may occur. Re-evaluate if insomnia persists after 7 to 10 days of use. Impairment of alertness and motor coordination. Use with caution and monitor closely in patients with hepatic impairment.
  • Pregnancy: Crosses the placenta. No studies in pregnant women. Nursing mothers: Infant exposure via breast milk. Pediatric use: Safety and effectiveness not established.
  • Enhanced CNS-depressant effects with combination use, decreased alertness with imipramine, combination use with rifampicin decreases zolpidem effects. Ketoconazole increases exposure to and effect of zolpidem.
  • Drowsiness, dizziness and diarrhea.
  • Hypnotics